News

“HIV is a clever virus and has learned to evade even some of the best drugs on the market," said Dmitry Lyumkis, PhD.

The FDA’s decision follows the EU’s decision last month to similarly expand the scope of the drug’s approval to include more specific causes of vision loss and blindness.

In a dramatic decision on a long-running patent dispute over alirocumab vs. evolocumab, a federal court judge ruled that Amgen's patents were violated and that rivals Sanofi/Regeneron can no longer distribute their product.

Scientists have been busy in the lab. Molecules that release carbon-monoxide are considered the key to developing a new antibiotic to fight gonorrhea.

Study results on the link between vitamin D and headache have a history of being ambiguous, but new research found more conclusive findings.

Researchers initiated a new phase 3 clinical trial for topical agent olumacostat glasaretil, a potential treatment for acne vulgaris.

Previous studies have shown that “the gut microbiota differs in composition and diversity during the first months of life in children who later do or do not have allergic disease," but researchers who focused on immunoglobulin A prevalence made a different finding.

The National Institutes of Health (NIH) is enrolling participants from 45 sites around the world to evaluate cabotegravir as long-acting injectable pre-exposure prophylaxis (PrEP).

At the one-month follow-up exam, only 7% were functional non-responders, half of whom were reclassified as responders at 6-month follow-up.

While the culprit for the stomach pain and discomfort in autistic children was unknown for quite some time, new research suggests it could be caused by an “increased reaction to stress”.

The tendency of the brain to shrink with age may be reversed with a Mediterranean-style diet, UK researchers found.

Monitoring Zika-exposed patients for visual symptoms and ocular findings is particularly important because these may be the only indicators of the infection in some patients.

Dutch researchers used radiolabeling to observe certolizumab in the body for the first time. Such studies could provide a greater understanding of how TNF inhibitors can be best used in the treatment of inflammatory conditions like arthritis.

The rise in drug resistance against the human immunodeficiency virus (HIV) could have a negative impact on costs associated with the disease.

Children born to obese parents may be facing developmental delays, a study from the National Institutes of Health has found. The study looked at obese fathers as well as mothers.

People with multiple sclerosis tend to have sleep apnea, but not the usual kind, a study found.

Researchers sought to debunk the myth of a causal relationship between the pill and decreased libido in women.

In a formal letter to Congress, the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and American College of Physicians urged Congress to fight the GOP plans to dismantle the Affordable Care Act.

A novel cross-cultural adaptation of the Urticaria Control Test (UCT) for clinical applications in Thailand proved every bit as effective as its German predecessor.

Should physicians critically reconsider their management strategy for ACS in a broad spectrum of patients with ACS

Deeming Xaracoll to be a drug/device combination, the Food and Drug Administration notified Innocoll yesterday that it would not be going forward with the New Drug Application they had filed for the product in October.

From observations about butter and questions about acne to findings about flu shots and platypus venom, dozens of fascinating studies came out in 2016 regarding the disease.

The FDA has issued a complete response letter for the oral and intravenous antibiotic solithromycin as a treatment for patients with community-acquired bacterial pneumonia, due to concerns over hepatotoxicity and manufacturing issues.

The MD Magazine editors rounded up the 10 best stories from December—did you read them all?

Some cases of tubulointerstitial nephritis and uveitis syndrome, or TINU, have a poor visual prognosis, so early diagnosis and treatment are recommended. Diagnosis requires detailed history taking, whole-body imaging studies, and examination of renal function.

The FDA has approved Adynovate (PEGylated antihemophilic factor [recombinant]) as a treatment for hemophilia A in pediatric patients under 12 years of age and for both adults and pediatric patients in the surgical setting, based on findings from a phase 3 trial.

Between daily news and conferences around the country, it was a busy year in fibromyalgia research.

The FDA has approved nusinersen as a treatment for children and adults with spinal muscular atrophy (SMA), an often fatal genetic disease affecting muscle strength and movement.

The US Food and Drug Administration (FDA) is notifying doctors that LabCorp has reported false positive results from the ZIKV Detect test, made by InBios International. .

Between daily news and conferences around the country, it was a busy year in HIV/AIDS research.